Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)

被引：2
|
作者：
Abdelrahim, M. [1 ]
Esmail, A. [1 ]
He, A. R. [2 ]
Franses, J. [3 ]
Bhan, I. [4 ]
Victor, D. W. [5 ]
Kodali, S. [5 ]
Connor, A. A. [5 ]
Saharia, A. [5 ]
Brdiges, C. [6 ]
Tin, T. [7 ]
Brewer, C. [8 ]
Jurdi, A. [8 ]
Liu, M. C. [9 ]
Ghobrial, R. M. [5 ]
机构：
[1] Houston Methodist Neal Canc Ctr, Med Oncol Dept, Floor 24, Houston, TX USA
[2] Georgetown Univ, Comprehens Canc Ctr, Georgetown, WA USA
[3] Harvard Med Sch, Med Oncol Dept, Boston, MA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Med Oncol Dept, Boston, MA USA
[5] Houston Methodist, Liver Transplant, Houston, TX USA
[6] Natera Inc, MA, San Carlos, CA USA
[7] Natera, R&D, San Carlos, CA USA
[8] Natera Inc, Med Oncol Dept, San Carlos, CA USA
[9] Natera Inc, Oncol Dept, San Carlos, CA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
960P
引用
收藏
页码：S600 / S600
页数：1
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) testing for recurrence and treatment response monitoring in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Mejia, A.
    Esmail, A.
    Ouf, M.
    Franses, J. W.
    Bhan, I.
    Sudha, K.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Aushev, V.
    Palsuledesai, C. C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    He, A. R.
    ANNALS OF ONCOLOGY, 2024, 35 : S82 - S82
  • [2] Longitudinal and personalized detection of circulating tumor DNA (ctDNA) for monitoring efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma (HCC).
    Hsu, Chih-Hung
    Lu, Shan
    Abbas, Alex
    Guan, Yinghui
    Zhu, Andrew X.
    Aleshin, Alexey
    Lee, Kyung-Hun
    Lee, Michael Sangmin
    Mahipal, Amit
    Ryoo, Baek-Yeol
    Ding, Beiying
    Spahn, Jessica
    Verret, Wendy
    He, Aiwu Ruth
    Wang, Yulei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Personalized circulating tumor DNA testing for recurrence detection and treatment response monitoring in patients with metastatic invasive lobular carcinoma
    Oesterreich, Steffi
    Tin, Antony
    Rivero-Hinojosa, Samuel
    Fielder, Janie
    Ferguson, Jenifer
    Kalashnikova, Ekaterina
    Rodriguez, Angel
    Liu, Minetta
    Lee, Adrian
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Mutation profiles in circulating tumor DNA (ctDNA) to predict the efficacy of sorafenib treatment in patients with advanced hepatocellular carcinoma (HCC).
    Yang, Ping
    Ji, Guanghui
    Jiang, Qionghui
    Lu, Zejun
    Yu, Yao
    Yang, Yadong
    Jin, Ge
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Feasibility of personalized and tumor informed ctdna testing for recurrence monitoring in post-transplantation hepatocellular carcinoma
    Abdelrahim, M.
    Esmail, A.
    Saharia, A.
    McMillan, R.
    He, A. R.
    Starr, J.
    Dhani, H.
    Aushev, V.
    Malashevich, A. Koyen
    Hook, N.
    Gauthier, P.
    Billings, P.
    Rodriguez, A.
    Ghobrial, R. M.
    TRANSPLANTATION, 2022, 106 (8S) : 161 - 162
  • [6] Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab
    Mohamed, Yehia I.
    Lee, Sunyoung S.
    Demir, Tarik
    Chamseddine, Shadi
    Hu, Zishuo Ian
    Xiao, Lianchun
    Elsayes, Khaled
    Morris, Jeffrey S.
    Wolff, Robert A.
    Hiatia, Rikita
    Qayyum, Aliya
    Rashid, Asif
    Duda, Dan G.
    Yao, James C.
    LaPelusa, Michael
    Koay, Eugene J.
    Mahvash, Armeen
    Al Azzam, Ahmed
    Dumbrava, Ecaterina E.
    Hassan, Manal
    Amin, Hesham M.
    Kaseb, Ahmed Omar
    CANCER BIOMARKERS, 2024, 41 (01) : 83 - 91
  • [7] Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers
    Bellone, Stefania
    McNamara, Blair
    Mutlu, Levent
    Demirkiran, Cem
    Hartwich, Tobias Max Philipp
    Harold, Justin
    Yang-Hartwich, Yang
    Siegel, Eric R.
    Santin, Alessandro D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [8] Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring among patients with advanced or recurrent endometrial cancer
    Toboni, Michael
    Maxwell, Larry
    Scalise, Carly Bess
    Berman, Tara
    Hardesty, Melissa
    Ketch, Peter
    Hook, Nicole
    Bridges, Catherine
    Dutta, Punashi
    Liu, Minetta
    Arend, Rebecca
    ElNaggar, Adam
    Smitherman, Carson
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S208 - S209
  • [9] Circulating tumor DNA detection in hepatocellular carcinoma
    Cabel, L.
    Proudhon, C.
    Buecher, B.
    Pierga, J. -Y.
    Bidard, F. -C.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1094 - 1096
  • [10] Hepatocellular carcinoma (HCC): Monitoring of tumour response to treatment
    不详
    EUROPEAN RADIOLOGY, 1997, 7 (08) : B11 - B11
12345